{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T18:12:33Z","timestamp":1778091153280,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:00:00Z","timestamp":1749945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Association of Cancer Research","award":["IG21408"],"award-info":[{"award-number":["IG21408"]}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science Center in Cracow, Poland","award":["UMO-2024\/53\/B\/ST5\/00040"],"award-info":[{"award-number":["UMO-2024\/53\/B\/ST5\/00040"]}]},{"name":"Intramural Grant Funding"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108690","type":"journal-article","created":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T10:04:54Z","timestamp":1749981894000},"page":"108690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Two are better than one: A case study of the biferrocenyl-thymidine \u201cclick\u201d conjugate biFcT as novel ferroptosis-inducing agent in lung cancer cells"],"prefix":"10.1016","volume":"163","author":[{"given":"Angelo","family":"Meoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Riganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costanzo","family":"Costamagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemys\u0142aw","family":"Biega\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Kopecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108690_bb0005","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2025.108690_bb0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev."},{"key":"10.1016\/j.bioorg.2025.108690_bb0015","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1006\/bbrc.1999.1123","article-title":"Isolation of differentially expressed cDNAs from p53-dependent apoptotic cells: activation of the human homologue of the Drosophila peroxidasin gene","volume":"261","author":"Horikoshi","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2025.108690_bb0020","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41594-024-01329-z","article-title":"PRDX6 augments selenium utilization to limit iron toxicity and ferroptosis","volume":"31","author":"Fujita","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.108690_bb0025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1083\/jcb.201605110","article-title":"Heat stress induces ferroptosis-like cell death in plants","volume":"216","author":"Dist\u00e9fano","year":"2017","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bioorg.2025.108690_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112907","article-title":"Investigating the antibacterial activity of salen\/salophene metal complexes: induction of ferroptosis as part of the mode of action","volume":"209","author":"Baecker","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108690_bb0035","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/nph.16636","article-title":"Ferroptosis contributes to developmental cell death in rice blast","volume":"227","author":"Shen","year":"2020","journal-title":"New Phytol."},{"key":"10.1016\/j.bioorg.2025.108690_bb0040","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.37503","article-title":"Tryparedoxin peroxidase-deficiency commits trypanosomes to ferroptosis-type cell death","volume":"7","author":"Bogacz","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.bioorg.2025.108690_bb0045","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56580","article-title":"Changes in ferrous iron and glutathione promote ferroptosis and frailty in aging Caenorhabditis elegans","volume":"9","author":"Jenkins","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.bioorg.2025.108690_bb0050","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.chempr.2018.08.002","article-title":"Overcoming drug resistance by targeting Cancer bioenergetics with an Activatable prodrug","volume":"4","author":"Sharma","year":"2018","journal-title":"Chem"},{"key":"10.1016\/j.bioorg.2025.108690_bb0055","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/leu.2014.56","article-title":"Inhibitor of apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities","volume":"28","author":"Fulda","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bioorg.2025.108690_bb0060","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrc2889","article-title":"IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer","volume":"10","author":"Gyrd-Hansen","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.108690_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904197","article-title":"Recent progress in ferroptosis inducers for cancer therapy","volume":"31","author":"Liang","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioorg.2025.108690_bb0070","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","article-title":"Targeting ferroptosis opens new avenues for the development of novel therapeutics","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Trans. Target. Therapy"},{"key":"10.1016\/j.bioorg.2025.108690_bb0075","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1039\/D3CS00001J","article-title":"Stimuli-responsive ferroptosis for cancer therapy","volume":"52","author":"Kang","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2025.108690_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114861","article-title":"Ferroptosis-related small-molecule compounds in cancer therapy: strategies and applications","volume":"244","author":"Yin","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108690_bb0085","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","article-title":"Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress","volume":"33","author":"Tsoi","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2025.108690_bb0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2025.108690_bb0095","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1158\/0008-5472.CAN-16-1979","article-title":"HSPA5 regulates ferroptotic cell death in cancer cells","volume":"77","author":"Zhu","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.108690_bb0100","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/cbic.201500422","article-title":"Using small molecules to dissect non-apoptotic programmed cell death: necroptosis, ferroptosis, and pyroptosis","volume":"16","author":"Dong","year":"2015","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bioorg.2025.108690_bb0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","article-title":"Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells","volume":"3","author":"Dolma","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2025.108690_bb0110","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41598-018-19213-4","article-title":"The ferroptosis inducer erastin irreversibly inhibits system xc\u2212 and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells","volume":"8","author":"Sato","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108690_bb0115","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.28159","article-title":"Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib","volume":"133","author":"Louandre","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108690_bb0120","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2018.06.018","article-title":"CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer","volume":"432","author":"Kim","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2025.108690_bb0125","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1039\/D2SC06171F","article-title":"A chiral fluorescent Ir(III) complex that targets the GPX4 and ErbB pathways to induce cellular ferroptosis","volume":"14","author":"Zhao","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2025.108690_bb0130","doi-asserted-by":"crossref","first-page":"8174","DOI":"10.1002\/anie.202014959","article-title":"Ferroptosis photoinduced by new cyclometalated iridium(III) complexes and its synergism with apoptosis in tumor cell inhibition","volume":"60","author":"Yuan","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.108690_bb0135","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1039\/D3QI00908D","article-title":"Folate-targeted iridium complexes amplify photodynamic therapy efficacy through ferroptosis","volume":"10","author":"He","year":"2023","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.bioorg.2025.108690_bb0140","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1039\/D0NR08478F","article-title":"Nanoparticle-induced ferroptosis: detection methods, mechanisms and applications","volume":"13","author":"Zheng","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.bioorg.2025.108690_bb0145","article-title":"Mechano-responsive leapfrog micelles enable interactive apoptotic and Ferroptotic Cancer therapy","volume":"32","author":"Li","year":"2022","journal-title":"Adv. Func. Mater."},{"key":"10.1016\/j.bioorg.2025.108690_bb0150","doi-asserted-by":"crossref","first-page":"25257","DOI":"10.1021\/acsnano.3c08485","article-title":"Reversing Ferroptosis resistance in breast Cancer via tailored lipid and Iron presentation","volume":"17","author":"Luo","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioorg.2025.108690_bb0155","doi-asserted-by":"crossref","first-page":"8676","DOI":"10.1002\/chem.201904699","article-title":"Enhancing the activity of drugs by conjugation to organometallic fragments","volume":"26","author":"Chellan","year":"2020","journal-title":"Chem. A Eur. J."},{"key":"10.1016\/j.bioorg.2025.108690_bb0160","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1039\/D0CB00218F","article-title":"Brief survey on organometalated antibacterial drugs and metal-based materials with antibacterial activity","volume":"2","author":"Biega\u0144ski","year":"2021","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108690_bb0165","doi-asserted-by":"crossref","first-page":"17928","DOI":"10.1002\/chem.202103258","article-title":"Metallodrug profiling against SARS-CoV-2 target proteins identifies highly potent inhibitors of the S\/ACE2 interaction and the papain-like protease PLpro","volume":"27","author":"Gil-Moles","year":"2021","journal-title":"Chem. A Eur. J."},{"key":"10.1016\/j.bioorg.2025.108690_bb0170","doi-asserted-by":"crossref","first-page":"11797","DOI":"10.1021\/acs.chemrev.6b00166","article-title":"Organometallic\u2013peptide bioconjugates: synthetic strategies and medicinal applications","volume":"116","author":"Albada","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.108690_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2020.213658","article-title":"Multifaceted chemical behaviour of metallocene (M = Fe, Os) quinone methides, their contribution to biology","volume":"430","author":"Vessi\u00e8res","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.108690_bb0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/jm100020w","article-title":"Organometallic anticancer compounds","volume":"54","author":"Gasser","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108690_bb0185","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/1681039b0","article-title":"A new type of Organo-Iron compound","volume":"168","author":"Kealy","year":"1951","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108690_bb0190","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1021\/ja01128a527","article-title":"The structure of iron bis-cyclopentadienyl","volume":"74","author":"Wilkinson","year":"1952","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108690_bb0195","series-title":"Metallocenes-An Introduction to Sandwich Complexes","author":"Long","year":"1998"},{"key":"10.1016\/j.bioorg.2025.108690_bb0200","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1021\/om400962w","article-title":"Ferrocene \u2013 beauty and function","volume":"32","author":"Heinze","year":"2013","journal-title":"Organometallics"},{"key":"10.1016\/j.bioorg.2025.108690_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/ejic.202200388","article-title":"Special Collection: Ferrocene Chemistry","author":"\u0160t\u011bpni\u010dka","year":"2022","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108690_bb0210","doi-asserted-by":"crossref","first-page":"0066","DOI":"10.1038\/s41570-017-0066","article-title":"The medicinal chemistry of ferrocene and its derivatives","volume":"1","author":"Patra","year":"2017","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.bioorg.2025.108690_bb0215","doi-asserted-by":"crossref","first-page":"16865","DOI":"10.1021\/acs.jmedchem.1c00390","article-title":"Has ferrocene really delivered its role in accentuating the bioactivity of organic scaffolds?","volume":"64","author":"Sharma","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108690_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorganchem.2019.121017","article-title":"Ferrocenes in medicinal chemistry; a personal perspective","volume":"905","author":"Sansook","year":"2020","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.108690_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2022.214996","article-title":"A brief survey on the application of metal-catalyzed azide-alkyne cycloaddition reactions to the synthesis of ferrocenyl-x-1,2,3-triazolyl-R (x = none or a linker and R = organic entity) compounds with anticancer activity","volume":"479","author":"Kowalski","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.108690_bb0230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2018.04.008","article-title":"Recent developments in the chemistry of ferrocenyl secondary natural product conjugates","volume":"366","author":"Kowalski","year":"2018","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.108690_bb0235","article-title":"Ferroptosis-enhanced cancer immunity by a ferrocene-appended iridium(III) diphosphine complex","volume":"61","author":"Wang","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.108690_bb0240","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1039\/D1CC06742G","article-title":"Self-catalyzed tumor ferroptosis based on ferrocene conjugated reactive oxygen species generation and a responsive polymer","volume":"58","author":"Li","year":"2022","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2025.108690_bb0245","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1021\/acs.nanolett.3c02362","article-title":"In situ construction of ferrocene-containing membrane-bound nanofibers for the redox control of cancer cell death and cancer therapy","volume":"23","author":"Zhang","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioorg.2025.108690_bb0250","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.1039\/D4SC02002B","article-title":"How does ferrocene correlate with ferroptosis? Multiple approaches to explore ferrocene-appended GPX4 inhibitors as anticancer agents","volume":"15","author":"Li","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2025.108690_bb0255","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1039\/D4QI03268C","article-title":"Synthesis and bio-evaluation of aminoferrocene-based anticancer prodrugs as potent ferroptosis inducers","volume":"12","author":"Zhang","year":"2025","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.bioorg.2025.108690_bb0260","doi-asserted-by":"crossref","first-page":"9650","DOI":"10.1021\/acs.inorgchem.2c01110","article-title":"Electronic coupling in 1,2,3-Triazole bridged ferrocenes and its impact on reactive oxygen species generation and deleterious activity in Cancer cells","volume":"61","author":"Biega\u0144ski","year":"2022","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108690_bb0265","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0065-2792(08)60179-X","article-title":"Mixed valence chemistry-a survey and classification","volume":"10","author":"Robin","year":"1967","journal-title":"Adv. Inorg. Chem. Radiochem."},{"key":"10.1016\/j.bioorg.2025.108690_bb0270","doi-asserted-by":"crossref","first-page":"8872","DOI":"10.1038\/s41598-023-35978-9","article-title":"GPX4 overexpressed non-small cell lung cancer cells are sensitive to RSL3-induced ferroptosis","volume":"13","author":"Kim","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108690_bb0275","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbrc.2021.02.077","article-title":"miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549","volume":"549","author":"Deng","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2025.108690_bb0280","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrc2088","article-title":"Epidermal growth factor receptor mutations in lung cancer","volume":"7","author":"Sharma","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.108690_bb0285","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s42255-022-00591-z","article-title":"Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo","volume":"4","author":"Murphy","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.bioorg.2025.108690_bb0290","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4155\/fmc-2017-0317","article-title":"Anticancer metallodrugs: where is the next cisplatin?","volume":"10","author":"Hanif","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108690_bb0295","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1039\/D3DT04302A","article-title":"On the mechanism of action of arsenoplatins: arsenoplatin-1 binding to a B-DNA dodecamer","volume":"53","author":"Troisi","year":"2024","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2025.108690_bb0300","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/10715762.2020.1851027","article-title":"Protein carbonylation: molecular mechanisms, biological implications, and analytical approaches","volume":"55","author":"Akagawa","year":"2021","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bioorg.2025.108690_bb0305","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3400147","article-title":"Organelle-specific mechanisms in crosstalk between apoptosis and ferroptosis","author":"Wu","year":"2023","journal-title":"Hindawi Oxidative Med Cell. Longevity"},{"key":"10.1016\/j.bioorg.2025.108690_bb0310","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.cdd.4402028","article-title":"Apoptosome: a platform for the activation of initiator caspases","volume":"14","author":"Bao","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioorg.2025.108690_bb0315","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","article-title":"Mitochondria-targeted triphenylphosphonium-based compounds: synthesis, mechanisms of action, and therapeutic and diagnostic applications","volume":"117","author":"Zielonka","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.108690_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105514","article-title":"Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro","volume":"119","author":"Biega\u0144ski","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108690_bb0325","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-5793(97)00669-8","article-title":"JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis","volume":"411","author":"Salvioli","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2025.108690_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-26666-4_1","article-title":"Staining against Phospho-H2AX (\u03b3-H2AX) as a marker for DNA damage and genomic instability in Cancer tissues and cells","volume":"899","author":"Nagelkerke","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bioorg.2025.108690_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101328","article-title":"Insight into the mechanism of ferroptosis inhibition by ferrostatin-1","volume":"28","author":"Miotto","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.bioorg.2025.108690_bb0340","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/ja411006a","article-title":"Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models","volume":"136","author":"Skouta","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108690_bb0345","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41420-022-01212-0","article-title":"GPX4-independent ferroptosis\u2014a new strategy in disease's therapy","volume":"8","author":"Ma","year":"2022","journal-title":"Cell Death Discov."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500570X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500570X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:50:01Z","timestamp":1776919801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682500570X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":69,"alternative-id":["S004520682500570X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108690","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two are better than one: A case study of the biferrocenyl-thymidine \u201cclick\u201d conjugate biFcT as novel ferroptosis-inducing agent in lung cancer cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108690"}}